Discover 1,108 paid clinical trials in Hartford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,108
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for
Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer,
Location: New Haven CT, Boston MA, New York NY,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT05983432
Phase1, Recruiting
Revumenib in Combination With 7+3 + Midostaurin in AML
for
Acute Myeloid Leukemia, AML, Adult, AML With Gene Mutations,
Location: New Haven CT, Boston MA
Sponsor: Richard Stone, MD
Sex: All
Age: 18 - 70+
Code: NCT06313437
Phase1, Recruiting
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
for
Higher-risk Myelodysplastic Syndromes
Location: New Haven CT, Bronx NY, Columbia MD, Bethesda MD,
Sponsor: Akeso
Sex: All
Age: 18+
Code: NCT06196203
Phase2, Recruiting
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer,
Location: New Haven CT, Norwalk CT, New York NY, Montreal,
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: New Haven CT, Boston MA, New York NY, Philadelphia PA,
Sponsor: 858 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06395519
Phase1, Phase2, Recruiting
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
for
Advanced Adenocarcinoma
Location: New Haven CT, Cleveland OH, Detroit MI, Cincinnati OH,
Sponsor: BioAtla, Inc.
Sex: All
Age: 18+
Code: NCT05808634
Phase1, Recruiting
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: New Haven CT, The Bronx NY, New York NY,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All
Age: 18+
Code: NCT01042379
Phase2, Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: New Haven CT, Providence RI, Albany NY, Paramus NJ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase3, Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: New Haven CT, Boston MA, Paramus NJ, New York NY,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase3, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: New Haven CT, Boston MA, New York NY, Morristown NJ,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase3, Recruiting
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor, Solid Tumor
Location: New Haven CT, Hackensack NJ, New York NY, Ann Arbor MI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05981703
Phase1, Recruiting
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
for
Prostate Cancer
Location: New Haven CT, New York NY, Lebanon NH, Seattle WA
Sponsor: Yale University
Sex: Male
Age: 18+
Code: NCT06111781
Phase2, Recruiting
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
for
SCLC
Location: New Haven CT, Hackensack NJ, Fairfax VA, Buffalo NY,
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06179069
Phase1, Recruiting
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors, HNSCC, SCLC, NSCLC,
Location: New Haven CT, New York NY, Boston MA, Toronto,
Sponsor: Tubulis GmbH
Sex: All
Age: 18+
Code: NCT06657222
Phase1, Phase2, Recruiting
A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies
for
Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer,
Location: New Haven CT, Boston MA, Fairfax VA, Nashville TN,
Sponsor: Incendia Therapeutics
Sex: All
Age: 18+
Code: NCT05753722
Phase1, Recruiting
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
for
Breast Cancer, HER2-low Breast Cancer, Metastatic Breast Cancer,